tradingkey.logo

Codexis Inc

CDXS
View Detailed Chart

2.690USD

0.0000.00%
Close 08/01, 16:00ETQuotes delayed by 15 min
222.84MMarket Cap
LossP/E TTM

Codexis Inc

2.690

0.0000.00%
Intraday
1m
30m
1h
D
W
M
D

Today

+0.37%

5 Days

-13.50%

1 Month

-2.89%

6 Months

-37.00%

Year to Date

-43.61%

1 Year

-18.48%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 7 analysts
BUY
Current Rating
7.083
Target Price
163.32%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

552
Total
5
Median
6
Average
Company name
Ratings
Analysts
Codexis Inc
CDXS
7
CRISPR Therapeutics AG
CRSP
29
Intellia Therapeutics Inc
NTLA
28
Ionis Pharmaceuticals Inc
IONS
27
Exact Sciences Corp
EXAS
27
IQVIA Holdings Inc
IQV
25
1
2
3
...
111

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Sell
Sell(6)
Neutral(2)
Buy(2)
Indicators
Sell(2)
Neutral(2)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-0.112
Neutral
RSI(14)
45.918
Neutral
STOCH(KDJ)(9,3,3)
11.770
Oversold
ATR(14)
0.197
Low Volatility
CCI(14)
-115.486
Sell
Williams %R
86.335
Oversold
TRIX(12,20)
0.617
Sell
StochRSI(14)
3.112
Oversold
Moving Average
Sell(4)
Neutral(0)
Buy(2)
Indicators
Value
Direction
MA5
2.804
Sell
MA10
2.959
Sell
MA20
2.915
Sell
MA50
2.601
Buy
MA100
2.531
Buy
MA200
3.400
Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Codexis, Inc. is an enzyme engineering company. It is leveraging its CodeEvolver technology platform to discover, develop, enhance, and commercialize novel, high performance enzymes and other classes of proteins. It utilizes its CodeEvolver technology platform to develop optimized enzymes that are used by some pharmaceutical companies to reduce their costs and improve the efficiency and productivity of their manufacturing processes for small molecule therapeutics. It is developing its Enzyme-Catalyzed Oligonucleotide Synthesis (ECO Synthesis) manufacturing platform to enable the scaled manufacture of RNA interference (RNAi) therapeutics through an enzymatic route. It also uses the CodeEvolver platform technology to develop enzymes for the synthesis of nucleic acids, such as DNA/RNA, including enzymes utilized in its ECO Synthesis manufacturing platform, where its enzymes are poised to deliver many of the same benefits it offers in pharmaceutical manufacturing.
Ticker SymbolCDXS
CompanyCodexis Inc
CEODr. Stephen G. Dilly, Ph.D.
Websitehttps://www.codexis.com/
KeyAI